← Leaderboards
Oliver Delgado
Resonant Therapeutics, Inc.
$185,535
Attributed
$371,070
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$371,070 · 1
By mechanism
R43$371,070 · 1
Top collaborators
- Shaun M Stewart1 shared
Most similar at Resonant Therapeutics, Inc.
Same institution · by research overlap
- Shaun M Stewart$185,535
Others in their field
Other Rising Stars on “Antibody-Drug Conjugates”
- Jesse Mischa McFarland · Shasqi, Inc.$2,546,903
- Faith H Barnett · Resolute Science, Inc.$2,123,874
- Patricia Manuela Ribeiro Pereira · Washington University$2,069,397
- Oluwatosin Dada · Gmj Technologies, Inc.$1,947,901
- Guanghui Zong · Glycot Therapeutics, Llc$1,736,089
- Eugene Pietzak · Sloan-Kettering Inst Can Research$1,516,847
Research focus
Antibody-Drug ConjugatesBindingCancer CellCancer Cell LineCancer PatientCancer TherapyCarboplatinCell LineCellsCell SurfaceCessation Of LifeCharacteristicsConventional TherapyCytotoxicDesignDiagnosisDoseDrug ResistanceEffective TherapyEvaluationExatecanFda ApprovedFemaleAntibodies